Related Experiment Video
Updated: May 13, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Treatment Response in First-episode Schizophrenia
Rebecca Schennach1, Michael Riedel, Richard Musil
1Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
Summary
First episode schizophrenia (FES) patients often respond well to treatment, but some experience persistent psychosis. Identifying non-responders early is key to improving outcomes with targeted interventions.
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Psychology
Background:
- First episode schizophrenia (FES) patients demonstrate higher treatment responsiveness compared to chronic cases.
- Adequate treatment response in FES correlates with a more favorable long-term prognosis.
- Approximately 25% of FES patients exhibit persistent psychotic symptoms despite initial treatment.
Purpose of the Study:
- To review current evidence on response patterns in FES.
- To identify key predictors of treatment response and non-response in FES.
- To summarize effective treatment interventions for FES patients.
Main Methods:
- Systematic literature review of studies on FES treatment response.
- Analysis of clinical and biological variables associated with treatment outcomes.
- Evaluation of antipsychotic efficacy and the role of psychological interventions.
Main Results:
- Response patterns in FES vary, with a significant minority showing persistent symptoms.
- Several biological and clinical factors predict differential treatment response.
- Both pharmacological and psychological interventions are crucial for managing FES.
Conclusions:
- Early identification of non-responders in FES is critical for optimizing treatment strategies.
- A combination of antipsychotic medication and psychological therapies improves outcomes.
- Further research into predictors of non-response can guide personalized treatment approaches.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.